Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tatjana Buchholz"'
Autor:
Lutz Wobbe, Louise Schelletter, Hanna Berger, Birgit Gerlinde Katharina Mittmann, Tatjana Buchholz, Olaf Kruse, Olga Blifernez-Klassen, Thomas Baier, Maryna Soleimani, Viktor Klassen
Publikováno v:
The Plant cell. 33(4)
In green microalgae, prolonged exposure to inorganic carbon depletion requires long-term acclimation responses, involving modulated gene expression and the adjustment of photosynthetic activity to the prevailing supply of carbon dioxide. Here, we des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66aa11287d5a911f4e10adafd1538455
https://pubmed.ncbi.nlm.nih.gov/33793853
https://pubmed.ncbi.nlm.nih.gov/33793853
Autor:
Lutz Wobbe, Birgit Gerlinde Katharina Mittmann, Olaf Kruse, Louise Schelletter, Viktor Klassen, Hanna Berger, Maryna Soleimani, Tatjana Buchholz, Olga Blifernez-Klassen, Thomas Baier
In green microalgae, prolonged exposure to inorganic carbon depletion requires long-term acclimation responses, based on a modulated expression of genes and adjusting photosynthetic activity to the prevailing supply of carbon dioxide. Here, we depict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f243ef22f9e7d4aeb2b055c2bebeace
https://pub.uni-bielefeld.de/record/2946454
https://pub.uni-bielefeld.de/record/2946454
Publikováno v:
Human gene therapy. 28(10)
Plasmid DNA is currently gaining increasing importance for clinical research applications in gene therapy and genetic vaccination. For direct gene transfer into humans, good manufacturing practice (GMP)-grade plasmid DNA is mandatory. The same holds
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f42f2a5bbd47009bcf96941ee492fb34
https://pubmed.ncbi.nlm.nih.gov/28826233
https://pubmed.ncbi.nlm.nih.gov/28826233
Publikováno v:
Molecular Therapy. 24:S234
Amongst other applications, our plasmid DNA is used in the GMP-compliant production of recombinant viruses, antibodies and RNA, where these are the active pharmaceutical ingredients (API) used in clinical trials. Here, it is not always necessary to p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a845a9837be30f6a8f47abd1d0bbfa4
https://doi.org/10.1016/s1525-0016(16)33400-1
https://doi.org/10.1016/s1525-0016(16)33400-1
Autor:
Martin Schleef, Ram Shankar, Tatjana Buchholz, Hildegard Büning, Anja Grünert, Marco Schmeer, Maria Schnödt, Thomas Armin Fuchsluger
Publikováno v:
Molecular Therapy. 24:S123
Especially in gene therapy applications, certain sequence motifs contained in plasmid DNA have to be avoided wherever possible. Such sequences are e.g. the bacterial ori or selection markers, only used for controlling the bacterial replication of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56c265cf84f453c6c1caa3e38a004e3f
https://doi.org/10.1016/s1525-0016(16)33115-x
https://doi.org/10.1016/s1525-0016(16)33115-x